Ease of dressing removal · surgical wounds resulting from clean surgery and healing by primary intention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 · infants and children with pulmonary exacerbations in cystic fibrosis
1 finding from 1 review
Z score FVC · infants and children with pulmonary exacerbations in cystic fibrosis
1 finding from 1 review
HRCT score · infants and children with pulmonary exacerbations in cystic fibrosis
1 finding from 1 review
Weight (z score) · infants and children with pulmonary exacerbations in cystic fibrosis
1 finding from 1 review
Number of positive P aeruginosa isolates · infants and children with pulmonary exacerbations in cystic fibrosis
1 finding from 1 review
Number or proportion of hospitalisations · infants and children with pulmonary exacerbations in cystic fibrosis
1 finding from 1 review
Hospital costs · infants and children with pulmonary exacerbations in cystic fibrosis
1 finding from 1 review
All‐cause mortality · people with bloodstream infections
Rapid susceptibility methods showed no clear difference in mortality compared with standard methods versus placebo (low certainty).
1 finding from 1 review
Mortality (subgroup genotypic) · people with bloodstream infections
Rapid susceptibility methods showed no clear difference in mortality (subgroup genotypic) compared with standard methods versus placebo (low certainty).
1 finding from 1 review
Mortality (subgroup phenotypic) · people with bloodstream infections
Rapid susceptibility methods showed no clear difference in mortality (subgroup phenotypic) compared with standard methods versus placebo (low certainty).
1 finding from 1 review
Mortality (with stewardship) · people with bloodstream infections
Rapid susceptibility methods showed no clear difference in mortality (with stewardship) compared with standard methods versus placebo (low certainty).
1 finding from 1 review
Mortality (without stewardship) · people with bloodstream infections
Rapid susceptibility methods showed no clear difference in mortality (without stewardship) compared with standard methods versus placebo (low certainty).
1 finding from 1 review
Time to hospital discharge · people with bloodstream infections
1 finding from 1 review
Time‐to‐appropriate antibiotic · people with bloodstream infections
1 finding from 1 review
Intervention not reported
FEV1 change from start of treatment (L) · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
FEV1 change from start of treatment (% predicted) · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
Time to next exacerbation · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review
Intervention not reported
Adverse events: number of moderate adverse events · adults and children with cystic fibrosis and P aeruginosa
The intervention showed no clear difference in adverse events: number of moderate adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Sputum density: change in P aeruginosa sputum density (log1₀ CFU/g) · adults and children with cystic fibrosis and P aeruginosa
1 finding from 1 review